To evaluate the prognostic significance of CD47 and SIRPA expression in high-risk neuroblastoma, Kaplan–Meier survival analysis was performed on the high-risk neuroblastoma cohort [17,18]. The gene discussed is SIRPA; the disease is neuroblastoma.